Acerta Pharma B.V. (A member of the AstraZeneca Group)

  • Website: http://www.acerta-pharma.com
  • Size: 11-50 employees
  • Overview: Acerta Pharma has the responsibility of developing both internally discovered compounds as well as AstraZeneca sourced compounds for hematological malignancies. The company began operations in 2013 with the vision of combining cutting edge science, unique covalent technology, and an experienced, dedicated team in order to deliver novel targeted therapies for patients with cancer.

Search 1.5 billion
Email & Phone#

Browse to anyone's Linkedin profile, and Contactout will find that person's email address and phone number

Start your free trial
(300+ Reviews)

People also viewed these companies

  • Professional Training & Coaching
  • Biotechnology
  • Financial Services
  • Capital Markets
  • Information Technology and Services
  • Non-profit Organization Management
  • Business Supplies and Equipment